Economic evaluation of adding dapagliflozin to standard care in the treatment of chronic kidney disease: a systematic review
Abstract Introduction Chronic kidney disease is a significant public health issue. Dapagliflozin has been shown to improve the quality of life for patients with chronic kidney disease. This review aimed to systematically assess the cost-effectiveness of adding dapagliflozin to standard care compared...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | BMC Nephrology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12882-024-03901-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|